Celgosivir hydrochloride
≥98%
- Product Code: 99992
CAS:
141117-12-6
Molecular Weight: | 295.76 g./mol | Molecular Formula: | C₁₂H₂₂ClNO₅ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8℃ |
Product Description:
Celgosivir hydrochloride is primarily used in the research and development of antiviral therapies. It has shown potential in inhibiting the replication of certain viruses, particularly those in the flavivirus family, such as dengue and hepatitis C. The compound acts as an alpha-glucosidase inhibitor, disrupting the glycosylation process of viral proteins, which is crucial for viral maturation and infectivity. This mechanism makes it a candidate for antiviral drug development. Additionally, it has been explored for its potential in cancer research, where glycosylation inhibitors are studied for their ability to alter tumor cell behavior and enhance the efficacy of other treatments. Its application remains largely in the experimental and preclinical stages, with ongoing studies to evaluate its safety and effectiveness.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.001 | 10-20 days | ฿15,390.00 |
+
-
|
0.005 | 10-20 days | ฿35,910.00 |
+
-
|
Celgosivir hydrochloride
Celgosivir hydrochloride is primarily used in the research and development of antiviral therapies. It has shown potential in inhibiting the replication of certain viruses, particularly those in the flavivirus family, such as dengue and hepatitis C. The compound acts as an alpha-glucosidase inhibitor, disrupting the glycosylation process of viral proteins, which is crucial for viral maturation and infectivity. This mechanism makes it a candidate for antiviral drug development. Additionally, it has been explored for its potential in cancer research, where glycosylation inhibitors are studied for their ability to alter tumor cell behavior and enhance the efficacy of other treatments. Its application remains largely in the experimental and preclinical stages, with ongoing studies to evaluate its safety and effectiveness.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :